期刊文献+

Cardiopulmonary,complications in chronic liver disease 被引量:17

Cardiopulmonary complications in chronic liver disease
下载PDF
导出
摘要 有肝硬化和门静脉高血压的病人展出典型心血管、肺的血液动力学的变化。一个 vasodilatatory 状态和影响心脏、肺的功能的亢奋的动态发行量统治发行量。最近定义的肝脏硬化症的心肌症可以影响收缩、心脏舒张的功能,并且暗示机电的畸形。另外,循环 homoeostasis 的压力感受器功能和规定被损害。肺的机能障碍涉及在一些病人与肝肺症候群和 portopulmonary 高血压的发展传播畸形。最近的研究集中于血液动力学、神经元介质的 dysregulation 具有为在肝硬化的心血管、肺的复杂并发症的发展的主要重要性的断言。这个方面是重要的在这些病人的管理考虑。 Patients with cirrhosis and portal hypertension exhibit characteristic cardiovascular and pulmonary hemodynamic changes. A vasodilatatory state and a hyperdynamic circulation affecting the cardiac and pulmonary functions dominate the circulation. The recently defined cirrhotic cardiomyopathy may affect systolic and diastolic functions, and imply electromechanical abnormalities. In addition, the baroreceptor function and regulation of the circulatory homoeostasis is impaired. Pulmonary dysfunction involves diffusing abnormalities with the development of the hepatopulmonary syndrome and portopulmonary hypertension in some patients. Recent research has focused on the assertion that the hemodynamic and neurohumoral dysregulation are of major importance for the development of the cardiovascular and pulmonary complications in cirrhosis. This aspect is important to take into account in the management of these patients.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第4期526-538,共13页 世界胃肠病学杂志(英文版)
关键词 慢性肝疾病 并发症 心脏疾病 肺疾病 Cirrhosis Portal hypertension Cardiomyopathy Hemodynamics Vasoactive substances Baroreceptors Hepatopulmonary syndrome Portopulmonary hypertension Autonomic dysfunction
  • 相关文献

参考文献170

  • 1[1]Mφller S,Henriksen JH.In:Arroyo V,Gines P,Rodes J,Schrier RW,eds.Ascites and renal dysfunction in liver disease.Malden:Blackwell,1999:307-329
  • 2[2]Llach J,Gines P,Arroyo V,Rimola A,Tito L,Badalamenti S,Jimenez W,Gaya J,Rivera F,Rodes J.Prognostic value of arterial pressure,endogenous vasoactive systems,and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites.Gastroenterology 1988; 94:482-487
  • 3[3]Groszmann RJ,Jensen JE.Pathophysiology of portal hypertension.In:Kaplowitz N,ed.Liver and Biliary Diseases.2 ed.Baltimore:Williams & Wilkins,1996:551-562
  • 4[4]Mφller S,Wiinberg N,Hernriksen JH.Noninvasive 24-hour ambulatory arterial blood pressure monitoring in cirrhosis.Hepatology 1995; 22:88-95
  • 5[5]Mφller S,Bendtsen F,Henriksen JH.Splanchnic and systemic hemodynamic derangement in decompensated cirrhosis.Can J Gastroenterol 2001; 15:94-106
  • 6[6]Arroyo V,Colmenero J.Ascites and hepatorenal syndrome in cirrhosis:pathophysiological basis of therapy and current management.J Hepatol 2003; 38 Suppl 1:S69-89
  • 7[7]Kowalski HJ,Abelmann WH.Mcneely WF,Frank NR,Ellis LB.The cardiac output of normal subjects determined by the dye-injection method at rest and during exercise.Am J Med Sci 1954; 228:622-625
  • 8[8]Groszmann RJ.Hyperdynamic circulation of liver disease 40 years later:pathophysiology and clinical consequences.Hepatology 1994; 20:1359-1363
  • 9[9]Vallance P,Moncada S.Hyperdynamic circulation in cirrhosis:a role for nitric oxide? Lancet 1991; 337:776-778
  • 10[10]Groszmann RJ.Nitric oxide and hemodynamic impairment.Digestion 1998; 59 Suppl 2:6-7

同被引文献50

引证文献17

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部